Laura Joyce discusses Annex 11 and Teckro's alignment with it.

Brian Deighan highlights Teckro's capabilities for improvement when study teams use research data from site surveys.

The EMA has issued a reflection paper to improve single-arm trials design.

Lobbying for equitable clinical trial access in the US Cures 2.0 Act.

The FDA is mandating diversity plans for better health equity in clinical trials.

Aoife Delany blogs about clinical research and safe treatments during pregnancy.

Results must be reported within a year of completion or face penalties.

Hannah Lippitt revisits a chat on making investigator meetings lively and effective.

The UK government is reviewing ways to address the decline of clinical trials.

Reflections on Ira Feinstein's podcast and experiences as a transgender man.

Teckro's Siobhan McKenna emphasizes clinical experience as part of useful trial tech.

Hannah Lippitt shares a success story on clinical trials as a treatment option.

Teckro's Aoife Delany delves into anti-depressant drugs and a future beyond SSRIs.

Hannah Lippitt recalls talking with Ukrainian PI and Teckro user Dr. Roman Fishchuk.

Former CRA Maria Milas summarizes Europe's CTIS for unified clinical study approval.

Addressing international healthcare disparities is a key focus for the WHO in 2023.

Teckro's Rob Alves discusses prioritizing end user needs in product design.

Teckro's Mia Li explores the success of digital video within clinical trial operations.

Teckro's Aoife Delany asks why Alzheimer's research routinely neglects to focus on females.

A look at Pediatric expert Dr. Martine Dehlinger-Kremer's keynote on children in trials.

Reflections on a conversation about secure secondary use of patient data in trial design.

Reflections on the story of an LGBTQ+ cancer survivor and advocate.

Teckro's Rachel Baldwin writes about finding common ground on the topic of DEI.

Dr. Brendan Buckley describes the zombie continuing to haunt clinical trials.

Kelly Brown shares her analysis of the SCRS Global Site Solutions Summit.

Grayson Scott from Centricity Research, describes how Teckro supports daily duties.

Teckro's Peter Gray explains how to lower cost and improve efficiency.

Guests Dr Jorge Velasco Zamora and Mónica Coronel analyze the PI role in trials.

Guest experts Jenn Weinberg and Liz Corcoran dissect the clinical research staff exodus.

Clara MacKay blogs about addressing bias and barriers in LGBTQ+ ovarian cancer care.

Site advocate Silvina Baudino blogs about diversity, inclusion and education through art.

Mia Li shares the advantages of applying digital strategies to clinical trial operations.

CEO Gary Hughes introduces Teckro's new partnership with non-profit One Tree Planted.

Malia Lewin reflects on clinical trial inclusion following a LGBTQ+ focus group.

Jeanne Hecht examines Teckro's role in environmental, social and governance goals.

Site advocate Silvina Baudino describes her own frustration in seeking out clinical trials.

Aoife Delany calls for more research into links between diabetes and COVID-19.

Kelly Brown reflects on big topics from the SCRS Diversity Site Solutions Summit.

Malia Lewin examines sustainability trends, patient outcomes and reduced costs.

What we learned about technology from frontline clinical research staff at ACRP.

Teckro's Jana Haddow explains what motivates her and the stress of paper protocols.

Teckro's Rachel Baldwin summarizes the industry data on research site engagement.

Teckro's ACRP focus group on the fragmented workflow of clinical research.

Patient advocate and person with Parkinson's Cathy Molohan busts popular myths.

Sonia Araujo pays tribute to her late aunt and reflects on the fight against brain cancer.

Diverse cancer trial patient recruitment is key in a new plan to halve the death rate.

Industry consultant Jeanne Hecht reports the positive impact and value of Teckro.

Guest Chelsea McCabe writes about navigating oncology clinical trial complexities.

The US has introduced the bipartisan DEPICT act for increased clinical trial diversity.

Malia Lewin emphasizes clinical trials as best possible oncology care.

The European Regulation and portal aim for efficiency and transparency in clinical trials.

Study site advocate Silvina Baudino explains what it means to be an SCRS GIP.

Teckro's Gary Hughes on what makes companies move from average to exceptional.

Rory McConnell talks about Teckro's targeted, segmented guidance at the point of care.

Teckro's Aoife Delany highlights the importance of clinical trials for diabetes.

Kelly Brown shares what's behind the awesome industry podcast giving voice to stakeholders.

Malia Lewin calls for cancer care equality for the millions of women diagnosed.

Kelly Brown reflects on Teckro being at the 2021 GSSS and shares plans for site success.

Brendan Buckley reflects on what we can do to help those who lack healthy vision.

Sonia Araujo reflects on being inspired by the 19th-century mathematician.

Teckro takes the view that more females are needed in cardiovascular clinical trials.

Malia Lewin reflects on her webinar and gives top tech tips to sites and sponsors.

Maria Milas explains how Teckro makes life easy for clinical research associates.

Expert guest Lydia Beaudette examines how “intuitive” tech helps site staff thrive.

Gary Hughes describes how Teckro's simple, intuitive design delivers impact.

On World Hepatitis Day 2021, Teckro writes about effective diagnosis and treatments.

Malia Lewin blogs about using the best tools for oncology trials.

Dr. Brendan Buckley writes about the need for active rather than passive patient participation.

Why a virtual approach is just one aspect of modernizing clinical trials.

Dr. Brendan Buckley examines clinical trial access issues for DeafBlindness patients.

A blog on game-changing clinical trial behavioral data for CROs and sponsors.

Teckro's Kelly Brown salutes those who give the gift of life through blood donation.

We summarize our 2021 OCT East Coast presentation

Teckro runs a virtual 5k for the Clearity Foundation’s Teal Revolution 2021.

Dr. Brendan Buckley takes a closer look at the wide spectrum of clinical trials.

CEO Gary Hughes compares game-changing Teckro to humans first finding fire.

Teckro writes about how going digital saves trees and reduces the carbon footprint.

Kate Penn explores the curious human mind and trial quality management.

Teckro writes about global accessibility, diversity and equity in clinical research.

Andrea Parish writes about better outcomes with Teckro.

Kelly Brown reflects on the last twelve months as well as three positive established trends.

Teckro's Gary Hughes talks leaving bias behind to create unity for stakeholders.

Teckro's Dr. Brendan Buckley on the current state of rare disease research.

How Teckro helps biotechs run fast, safe, cost-efficient clinical trials.

CEO Gary Hughes wants cancer research to match COVID-19 research speed.

Teckro’s view on how the HPV vaccine could end cervical cancer by 2030.

Teckro CEO Gary Hughes blogs about trial speed, tech, diversity and transparency.

In part two of this series, Andrea Parish delves into Teckro's unique features.

In part one of this series, Andrea Parish looks at tech uptake in trial monitoring.

Gary Hughes describes how Teckro allows research staff to directly reach study experts.

Teckro's Gary Hughes says why clinical trial data transparency is particularly important today.

World Ovarian Cancer Coalition CEO Clara MacKay talks testing and treatment.

It's time for a 21st Century mobile smartphone clinical trial protocol reference tool.

Teckro's Gary Hughes writes about COVID-19 disruptions and tech for cancer trials.

Teckro's Kelly Brown considers the clinical trial diversity gap and sponsor-site partnerships.

Do clinical trial protocol "cheat sheets" actually give research staff immediate answers?

Drug development expert Dr. Ellen Vigdorth writes about faster, safer, vaccine trials.

Dr. Brendan Buckley explores why access to clinical trial protocols are so outdated.

Teckro CEO and co-founder Gary Hughes reflects on the five year company journey.

Teckro's Kelly Brown explores accessibility, inclusion and diversity of patients in trials.

Teckro helps physicians understand how and why they should get into clinical trials.

FAQs on clinical trial accessibility to improve inclusion and diversity.

Program Lead Rita Frawley blogs about the challenges sponsors face in cancer trials.

Biostatistician Victoria Cooley talks about improving trial data quality with digitalization.

Guidance to protect patient safety and ongoing clinical trials data integrity.

Teckro’s Kelly Brown calls for simpler ovarian cancer trials to get crucial drugs to market.

Chief Technology Officer and Co-Founder Jacek Skrzypiec writes about innovation.

Teckro's Gary Hughes writes how clinical trials must evolve amongst global disruption.

Andrea Parish discusses how risk-based monitoring could be a solution to current needs.

CEO Gary Hughes confirms client support for ongoing trials during the pandemic.

On International Women’s Day, Teckro's Kelly Brown talks about gender diversity in trials.

CEO Gary Hughes explains the importance of ethnic diversity in clinical trials.

Discover how Teckro helps get crucial cancer drugs to market quickly and safely.

Teckro's Gary Hughes dissects site communication issues to improve clinical trial success.

Teckro's Brian Deighan offers practical communication tips for clinical site engagement.

CEO Gary Hughes describes bridging the communication and data gaps in clinical trials.